Caplight Directory>Investors>Boehringer Ingelheim Venture Fund>Boehringer-ingelheim-venture


Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Germanyboehringer-ingelheim-venture.com

Overview

The Boehringer Ingelheim Venture Fund (BIVF) invests in groundbreaking therapeutics-focused biotechnology companies to drive innovation in biomedical research . BIVF is searching for significant enhancements in patient care through pioneering science and its clinical translation by building long-term relationships with scientists and entrepreneurs . BIVF's focus is to target unprecedented therapeutic concepts addressing high medical needs in immuno-oncology, regenerative medicine, infectious diseases and digital health .

Year Founded

2010

Portfolio Companies

32

Investments

CompanyDateStageLead
TacalyxApr 2026SeedCo-investor
TECregenJan 2026SeedLead
STRM.BIODec 2025Series Seed 2Co-investor
smartbax GmbHOct 2025pre_series_aCo-investor
NuevocorMay 2025Series BCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersGermany
Year Founded2010

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.